Floatz logo

Ambroxol

Abnormal Mucus Secretions

Zambon SpASmall moleculePhase 3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Abnormal Mucus Secretions cohort.

Asset / SponsorPhaseRating
N-Acetyl-L-Cysteine
Zambon SpA
Phase 3BB
gs-9411
Gilead Sciences
Phase 1NR

Same molecule, other indications

Ambroxol is also rated in:

Parkinson diseaseDormant
BB
Indicative ·
65 / 100
View asset →
GBA1-related Parkinson disease, susceptibilityDormant
BB
Indicative ·
64 / 100
View asset →
respiratory system disorderDormant
B
Indicative ·
62 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →